GMAB vs FDXF Comparison

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

FedEx Freight Holding Co Inc is a North America-based less-than-truckload (LTL) transportation and freight services provider. Its service offerings - including Priority, Economy, and Direct shipping services - enable customers to select transportation options based on their needs. The company operates a network of vehicles and service locations across the U.S. states, Canada, Mexico, Puerto Rico, and the U.S. Virgin Islands, providing freight transportation and logistics services. It also utilizes data-driven technology and sales operations to support its transportation network and customer services.